Orange Book product · Brand (NDA)
ONTRALFY
TIZANIDINE HYDROCHLORIDE
At a glance
Dec 12, 2024
Approved
Brand (NDA)
Application
Not listed
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 12, 2024
1 yr 6 mo ago
Today
Patent 12042484 expires
Listed drug product patent expiration.
May 07, 2042
in 16 yr 1 mo
Patent 12263158 expires
Listed drug product patent expiration.
May 07, 2042
in 16 yr 1 mo
Pharmaceutical detail
Active ingredient
TIZANIDINE HYDROCHLORIDE
Strength
EQ 2MG BASE/5ML
Dosage form
SOLUTION
Route
ORAL
TE code
Not listed
Application
NDA 216190
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2002ZANAFLEXBrand (NDA)
NDA 021447 · LEGACY PHARMA USA
- 2000ZANAFLEXBrand (NDA)
NDA 020397 · LEGACY PHARMA USA
- 2024TIZANIDINE HYDROCHLORIDEGeneric (ANDA)
ANDA 218920 · RISING
- 2024TIZANIDINE HYDROCHLORIDEGeneric (ANDA)
ANDA 213365 · SENORES PHARMS
- 2020TIZANIDINE HYDROCHLORIDEGeneric (ANDA)
ANDA 213798 · RUBICON RESEARCH
- 2020TIZANIDINE HYDROCHLORIDEGeneric (ANDA)
ANDA 213544 · AUROBINDO PHARMA LTD
- 2020TIZANIDINE HYDROCHLORIDEGeneric (ANDA)
ANDA 213223 · ALEMBIC
- 2019TIZANIDINE HYDROCHLORIDEGeneric (ANDA)
ANDA 212196 · ALKEM LABS LTD
- 2019TIZANIDINE HYDROCHLORIDEGeneric (ANDA)
ANDA 210021 · CADILA PHARMS LTD
- 2019TIZANIDINE HYDROCHLORIDEGeneric (ANDA)
ANDA 210267 · INGENUS PHARMS LLC
- 2019TIZANIDINE HYDROCHLORIDEGeneric (ANDA)
ANDA 211798 · ALKEM LABS LTD
- 2018TIZANIDINE HYDROCHLORIDEGeneric (ANDA)
ANDA 208187 · CADILA
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 12042484 | May 07, 2042 | in 16 yr 1 mo | ProductU-2779 |
| 12263158 | May 07, 2042 | in 16 yr 1 mo | ProductU-2779 |

